These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 31880071

  • 21. Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population.
    Wu Y, Wu S, Yang E, Zhang G, Shi Q, Liang J, Lian X, Xu J.
    Calcif Tissue Int; 2023 Aug; 113(2):207-215. PubMed ID: 37401976
    [Abstract] [Full Text] [Related]

  • 22. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD.
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [Abstract] [Full Text] [Related]

  • 23. Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis.
    Wang QF, Bi HS, Qin ZL, Wang P, Nie FF, Zhang GW.
    Front Endocrinol (Lausanne); 2020 May; 11():571549. PubMed ID: 33101205
    [Abstract] [Full Text] [Related]

  • 24. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population.
    Dai Z, Wang R, Ang LW, Yuan JM, Koh WP.
    Bone; 2016 Feb; 83():171-177. PubMed ID: 26555636
    [Abstract] [Full Text] [Related]

  • 25. Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women.
    Hu W, He J, Fu W, Wang C, Yue H, Gu J, Zhang H, Zhang Z.
    J Clin Densitom; 2019 Feb; 22(2):179-184. PubMed ID: 30228048
    [Abstract] [Full Text] [Related]

  • 26. Declining serum bone turnover markers are associated with the short-term positive change of lumbar spine bone mineral density in postmenopausal women.
    Zhao S, Mo X, Wen Z, Liu M, Chen Z, Lin W, Huang Z, Chen B.
    Menopause; 2022 Jan 31; 29(3):335-343. PubMed ID: 35102102
    [Abstract] [Full Text] [Related]

  • 27. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A, Glover SJ, Eastell R.
    Bone; 2009 Dec 31; 45(6):1044-52. PubMed ID: 19665601
    [Abstract] [Full Text] [Related]

  • 28. Bone Turnover Markers for Osteoporosis Status Assessment at Baseline in Postmenopausal Pakistani Females.
    Naeem ST, Hussain R, Raheem A, Siddiqui I, Ghani F, Khan AH.
    J Coll Physicians Surg Pak; 2016 May 31; 26(5):408-12. PubMed ID: 27225148
    [Abstract] [Full Text] [Related]

  • 29. Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients.
    Zhu Y, Shen J, Cheng Q, Fan Y, Lin W.
    Clin Interv Aging; 2016 May 31; 11():1117-21. PubMed ID: 27574411
    [Abstract] [Full Text] [Related]

  • 30. Application of bone turnover markers and DXA and QCT in an elderly Chinese male population.
    Yuan Y, Zhang P, Tian W, Deng X, Yue R, Ge X, Li X.
    Ann Palliat Med; 2021 Jun 31; 10(6):6351-6358. PubMed ID: 34237958
    [Abstract] [Full Text] [Related]

  • 31. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
    Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA, IOF-IFCC Bone Marker Standards Working Group.
    Osteoporos Int; 2011 Feb 31; 22(2):391-420. PubMed ID: 21184054
    [Abstract] [Full Text] [Related]

  • 32. [Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].
    Ageev FT, Barinova IV, Seredenina EM, Orlova IaA, Kuz'mina AE, Masenko VP, Kochetov AG.
    Kardiologiia; 2013 Feb 31; 53(6):51-8. PubMed ID: 23953046
    [Abstract] [Full Text] [Related]

  • 33. Study on the Effect of Bushen Zhuanggu Tablet Combined with Conventional Regimen on Bone Mineral Density Improvement, Functional Recovery and Fracture Risk Prevention in Patients with Postmenopausal Osteoporosis.
    Chen T, Li G, Xu Y.
    Comput Math Methods Med; 2023 Feb 31; 2023():4846392. PubMed ID: 37455682
    [Abstract] [Full Text] [Related]

  • 34. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
    Kharroubi A, Saba E, Smoom R, Bader K, Darwish H.
    Arch Osteoporos; 2017 Dec 31; 12(1):13. PubMed ID: 28124221
    [Abstract] [Full Text] [Related]

  • 35. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC.
    Osteoporos Int; 2000 Dec 31; 11(4):295-303. PubMed ID: 10928218
    [Abstract] [Full Text] [Related]

  • 36. Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female.
    Pan C, Liu X, Li T, Wang G, Sun J.
    J Orthop Surg Res; 2018 Dec 07; 13(1):314. PubMed ID: 30526635
    [Abstract] [Full Text] [Related]

  • 37. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    Crandall CJ, Vasan S, LaCroix A, LeBoff MS, Cauley JA, Robbins JA, Jackson RD, Bauer DC.
    J Bone Miner Res; 2018 Jul 07; 33(7):1199-1208. PubMed ID: 29923225
    [Abstract] [Full Text] [Related]

  • 38. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
    Mawatari T, Ikemura S, Matsui G, Iguchi T, Mitsuyasu H, Kawahara S, Maehara M, Muraoka R, Iwamoto Y, Nakashima Y.
    Bone Rep; 2020 Jun 07; 12():100275. PubMed ID: 32462056
    [Abstract] [Full Text] [Related]

  • 39. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD.
    Osteoporos Int; 2013 Feb 07; 24(2):489-94. PubMed ID: 22525978
    [Abstract] [Full Text] [Related]

  • 40. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
    Grampp S, Genant HK, Mathur A, Lang P, Jergas M, Takada M, Glüer CC, Lu Y, Chavez M.
    J Bone Miner Res; 1997 May 07; 12(5):697-711. PubMed ID: 9144335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.